Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.

Lawrence L, Danese P, DeVito J, Franceschi F, Sutcliffe J.

Antimicrob Agents Chemother. 2008 May;52(5):1653-62. doi: 10.1128/AAC.01383-07. Epub 2008 Mar 3.

PMID:
18316525
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.

Patel R, Rouse MS, Piper KE, Steckelberg JM.

Diagn Microbiol Infect Dis. 1999 Jun;34(2):119-22.

PMID:
10354862
[PubMed - indexed for MEDLINE]
3.

Activity of linezolid against levofloxacin-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in Hong Kong.

Ho PL, Ng TK, Yung RW, Que TL, Yip EK, Tse CW, Yuen KY.

J Antimicrob Chemother. 2001 Oct;48(4):590-2. No abstract available.

PMID:
11581246
[PubMed - indexed for MEDLINE]
Free Article
4.
5.

In vitro activity of linezolid and 11 other antimicrobials against 566 clinical isolates and comparison between NCCLS microdilution and Etest methods.

Tubau F, Fernández-Roblas R, Liñares J, Martín R, Soriano F.

J Antimicrob Chemother. 2001 May;47(5):675-80.

PMID:
11328783
[PubMed - indexed for MEDLINE]
Free Article
6.

Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study.

Ross JE, Fritsche TR, Sader HS, Jones RN.

Int J Antimicrob Agents. 2007 Mar;29(3):295-301. Epub 2007 Jan 18.

PMID:
17239570
[PubMed - indexed for MEDLINE]
7.

Activity of linezolid against multi-resistant gram-positive bacteria from diverse hospitals in the United Kingdom.

Johnson AP, Warner M, Livermore DM.

J Antimicrob Chemother. 2000 Feb;45(2):225-30.

PMID:
10660506
[PubMed - indexed for MEDLINE]
Free Article
8.

Epidemiologic trends in nosocomial and community-acquired infections due to antibiotic-resistant gram-positive bacteria: the role of streptogramins and other newer compounds.

Jones RN, Low DE, Pfaller MA.

Diagn Microbiol Infect Dis. 1999 Feb;33(2):101-12. Review.

PMID:
10091033
[PubMed - indexed for MEDLINE]
9.

Activity of linezolid against Gram-positive cocci isolated in French hospitals as determined by three in-vitro susceptibility testing methods.

Muller-Serieys C, Drugeon HB, Etienne J, Lascols C, Leclercq R, Nguyen J, Soussy CJ.

Clin Microbiol Infect. 2004 Mar;10(3):242-6.

PMID:
15008946
[PubMed - indexed for MEDLINE]
10.
11.

In vitro activity of TR-700, the active ingredient of the antibacterial prodrug TR-701, a novel oxazolidinone antibacterial agent.

Schaadt R, Sweeney D, Shinabarger D, Zurenko G.

Antimicrob Agents Chemother. 2009 Aug;53(8):3236-9. doi: 10.1128/AAC.00228-09. Epub 2009 Jun 15.

PMID:
19528279
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

[Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].

Ertek M, Yazgi H, Aktaş E, Ayyildiz A, Parlak M.

Mikrobiyol Bul. 2003 Oct;37(4):235-40. Turkish.

PMID:
14748259
[PubMed - indexed for MEDLINE]
13.

[Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].

Li JT, Li Y, Wang J; China Bacterial Resistance Surveillance Study Group.

Zhonghua Yi Xue Za Zhi. 2003 Mar 10;83(5):365-74. Chinese.

PMID:
12820911
[PubMed - indexed for MEDLINE]
14.

Global in vitro activity of tigecycline and linezolid against Gram-positive organisms collected between 2004 and 2009.

Dowzicky MJ, Chmelařová E.

Int J Antimicrob Agents. 2011 Jun;37(6):562-6. doi: 10.1016/j.ijantimicag.2011.02.004. Epub 2011 Apr 14.

PMID:
21497066
[PubMed - indexed for MEDLINE]
15.

Activities of ceftobiprole, linezolid, vancomycin, and daptomycin against community-associated and hospital-associated methicillin-resistant Staphylococcus aureus.

Leonard SN, Cheung CM, Rybak MJ.

Antimicrob Agents Chemother. 2008 Aug;52(8):2974-6. doi: 10.1128/AAC.00257-08. Epub 2008 Jun 2.

PMID:
18519721
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci.

Noskin GA, Siddiqui F, Stosor V, Hacek D, Peterson LR.

Antimicrob Agents Chemother. 1999 Aug;43(8):2059-62.

PMID:
10428937
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

In vitro activities of linezolid and tigecycline against methicillin-resistant Staphylococcus aureus strains.

Kaya O, Akcam FZ, Temel EN.

Microb Drug Resist. 2008 Jun;14(2):151-3. doi: 10.1089/mdr.2008.0801.

PMID:
18494600
[PubMed - indexed for MEDLINE]
19.

[In vitro susceptibility to linezolid in methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus strains].

Efe S, Sinirtaş M, Ozakin C.

Mikrobiyol Bul. 2009 Oct;43(4):639-43. Turkish.

PMID:
20084917
[PubMed - indexed for MEDLINE]
20.

[Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].

Manfredi R.

Recenti Prog Med. 2007 Mar;98(3):143-54. Review. Italian.

PMID:
17484159
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk